Bangavax Covid-19 vaccine to get conditional approval for human trials: BMRC

The National Research Ethics Committee of Bangladesh Medical Research Council (BMRC) on Wednesday decided to approve Globe Biotech's Covid-19 vaccine, Bangavax, for human trials

Globe Biotech will get the final nod on conducting clinical trials on humans only after meeting some conditions set by the BMRC, its director Prof Dr Ruhul Amin said this after a virtual meeting, reports UNB.

On January 17, Globe Biotech, the only Bangladeshi company trying to develop a Covid-19 vaccine, submitted a protocol to the BMRC for ethical approval to conduct Bangavax’s clinical trials.